Information on COVID-19 vaccination

The brand names of the vaccines used in Uusimaa are Comirnaty by BioNTech-Pfizer, Covid-19 Vaccine Moderna by Moderna, and COVID-19 Vaccine AstraZeneca by AstraZeneca.

BioNTech-Pfizer’s and Moderna’s vaccines are used for the elderly. They are a new type of mRNA vaccine. You can read more about mRNA vaccines on THL’s website.

AstraZeneca’s vaccine will be used for vaccinating people under 70. It is an adenovirus-vector vaccine. You can find more information on adenovirus vaccines on THL’s website.

The selection of vaccines can be expected to expand in the future.

The coronavirus vaccine involves two doses, the latter of which will be injected 12 weeks after the first one. The 12-week dosing interval will be gradually adopted to replace the previously planned 4-week interval. Municipalities will inform inhabitants if an already scheduled booster vaccine needs to be rescheduled.

If there is any delay with the booster vaccine, the second dose should be injected as soon as possible.

The vaccination order is based on the order of COVID-19 vaccinations as proposed by the National Institute for Health and Welfare of Finland (THL).

COVID-19 vaccine protects against the COVID-19 disease and especially its severe forms.

It is not yet known for certain whether the BioNTech-Pfizer’s and Moderna’s vaccines prevent transmission between people. According to preliminary data, the AstraZeneca vaccine reduces transmission.

Even after the vaccination, it is still important to maintain a safe distance to others, exercise proper hand hygiene and cough etiquette, wear a mask, get tested in case symptoms emerge and follow all the other instructions to prevent the COVID-19 disease from spreading. You can read instructions on THL’s website.

The immunity duration and potential need for further booster vaccinations are also not known yet.

Any vaccine can cause side effects. The majority of vaccine-related adverse reactions occur within six weeks of vaccination.

The most common symptoms caused by a vaccine include symptoms on the injection site, such as discomfort, redness, heat and swelling. Temporary general symptoms are also very common, such as fatigue, headache, muscle and joint pain, chills, nausea, and fever.

Both localized and general symptoms usually occur within two days of vaccination. They pass in a few hours or days. They can be treated with fever and pain medication. These symptoms do not prevent you from further vaccination.

Other adverse effects, such as severe allergic reactions, have been very rare.

Authorities are always monitoring the safety of vaccines after deployment.

  • The BioNTech-Pfizer vaccine will not be used for those under the age of 16 since there is not enough scientific data on the vaccination of this age group. For the same reason, Moderna’s and AstraZeneca’s vaccines will not be used in under 18-year-old people.
  • People who have a fever or a feverish infection. In such cases, the vaccination will be delayed. A confirmation message will be sent upon booking an appointment. The message includes instructions for changing the time of appointment.
  • If the first vaccine dose or one of its ingredients caused an anaphylactic reaction on the person.
  • Under the precautionary principle, people undergoing pregnancy will not be vaccinated, save in exceptional circumstances, since there is currently not enough data on the vaccination of pregnant women. A pregnant woman may be vaccinated if she has a high risk of a severe coronavirus infection. Breastfeeding does not prevent one from being vaccinated.
  • BioNTech-Pfizer’s and Moderna’s vaccines are not suitable for persons with polyethylene glycol (PEG) allergy.
  • The AstraZeneca vaccine is not suitable for persons with an allergy to polysorbate 80.

If you are scheduled for surgery, the vaccine should be given two weeks before the surgery or a week after it. The unit responsible for your treatment may give you different timing instructions.

If possible, we recommend maintaining an interval between administering the coronavirus vaccine and other vaccines so that it is easier to connect possible vaccine side effects to the correct vaccine. The interval between different vaccines should be at least 7 days.

There are no downsides to being vaccinated even if the person had a coronavirus infection in its incubation period. Those who have already recovered from a coronavirus infection should be vaccinated, at earliest, after 3 months since the onset of symptoms, or in case of a symptomless coronavirus infection, after 3 months the infection was confirmed.

Even those with prolonged symptoms can be vaccinated. The vaccination date should be changed if the person is in a very poor condition, the examination has not been completed yet or the symptoms have suddenly worsened.

It is not possible for people to choose which brand or type of vaccine is given to them. The National Advisory Committee on Vaccines has given recommendations on allocating the vaccines to different groups. The person receiving the vaccine or their doctor cannot choose a specific brand or type, but the vaccine used will be chosen according to the recommendations made by the National Advisory Committee on Vaccines.

Useful links: